Related Experiment Video
Updated: Jul 10, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
A study of cancer in the military beneficiary population
Raymond Shelton Crawford1, Julian Wu, Dae Park
1Division of Health Services Administration, Center for Population Health, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.
Abstract:
This study's objective was to describe: (1) patterns of cancer prevalence and type, (2) patient demographics, and (3) the sources, and cost, of medical care in the military beneficiary population using the Military Health System administrative databases. Calendar year 2002 patient enrollment, inpatient and outpatient encounter, and cost data from the 50 United States were analyzed to determine beneficiary cancer prevalence, demographics, source of care, cost of care, and cancer type. A total of 355,442 military beneficiaries were identified to have a cancer diagnosis (excluding nonmelanoma skin cancers) in 2002. More than two-thirds of these beneficiaries were over the age of 65, 55% were male, and 44% lived in three geographic areas of the country. Cancer of the prostate, breast, lung, and colon were most common. Almost 90% received their care outside of military medical treatment facilities and the overall cost of their care for 2002 was over $1 billion.
Related Concept Videos
Cancer Survival Analysis
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Treatment Resistant Cancers

